I recently posted about my father who had just completed IMRT and three years of Lupron (no mets seen on bone/CT scans). At the time his MO was suggesting adding Zytiga per studies showing its effectiveness with ADT at diagnosis for localized high grade cancer (he is Gleason 9). MO also ordered PSMA scan which is now available locally as a baseline, this is his first. PSA is 0.03.
PSMA scan showed two bone lesions, one on lower back (7mm) and one on upper back (5mm). Given the smaller size these were not seen on any initial CT or bone scan, or any non-PSMA scans done since diagnosis 3 years ago. They may have been there since the beginning hidden. I was surprised with the result since I had read PSMA wasn't super accurate with low PSA.
MO is starting my dad on the Zytiga and continuing Lupron. Plans to do another PSMA scan in a years time to check for any progression while of course monitoring PSA.
Given the discovery that the PCA horse has left the barn at some point, is there anything else that should be done beyond Lupron/Zytiga at this point? Is it worth it to spot treat these newly discovered spots with radiation if they aren't causing pain? Sounds like triplet therapy is only for newly discovered metastatic prostate cancer, correct?
Thanks in advance for the help...this site and its members have been an absolute blessing in understanding all of this.